The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression.
Open accessAbstract
B chronic lymphocytic leukemia (B-CLL) is characterized by the accumulation of slow-dividing and long-lived monoclonal B cells arrested at the intermediate stage of their differentiation. We previously showed that interleukin 4 (IL-4) not only inhibits but also prevents the proliferation of B-CLL cells. We report here that IL-4 protects the B-CLL cells from death by apoptosis (programmed cell death [PCD]). IL-4 inhibits spontaneous and hydrocortisone (HC)-induced PCD of highly purified B cells from 12 unselected CLL patients, as shown by sustained cell viability and lack of DNA fragmentation. IL-1, -2, -3, -5, -6, -7, tumor necrosis factor alpha, and transforming growth factor beta have no protective effect. The in vitro rescue from apoptosis by IL-4 is reflected by an increased expression of Bcl-2 protein, a proto-oncogene directly involved in the prolongation of cell survival in vivo and in vitro. Hence, IL-4-treated B-CLL cells express significantly more Bcl-2 than unstimulated, HC-treated, or fresh B-CLL cells. Furthermore, subcutaneous injection of IL-4 into one CLL patient enhances Bcl-2 protein expression in the leukemic B cells. These data may suggest that IL-4 prevents apoptosis of B-CLL cells using a Bcl-2-dependent pathway. Given our recent observations that fresh T cells from B-CLL patients express IL-4 mRNA, we propose that IL-4 has an essential role in the pathogenesis of CLL disease, by preventing both the death and the proliferation of the malignant B cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D. L., Cory, S., & Adams, J. M. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,219
Tsujimoto, Y., Finger, L. R., Yunis, J., Nowell, P. C., & Croce, C. M. (1984) · Science · doi:10.1126/science.6093263 · Cited by 1,769
Induction by Antigen of Intrathymic Apoptosis of CD4 + CD8 + TCR lo Thymocytes in Vivo
Murphy, K. M., Heimberger, A. B., & Loh, D. Y. (1990) · Science · doi:10.1126/science.2125367 · Cited by 1,735
BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.
Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., & Korsmeyer, S. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.6961 · Cited by 1,252
bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O., & Korsmeyer, S. J. (1991) · Cell · doi:10.1016/0092-8674(91)90361-2 · Cited by 1,194
Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E., & Rickinson, A. (1991) · Cell · doi:10.1016/0092-8674(91)90007-l · Cited by 1,168
Mechanism of antigen-driven selection in germinal centres
Liu, Y.-J., Joshua, D. E., Williams, G. T., Smith, C. A., Gordon, J., & MacLennan, I. C. M. (1989) · Nature · doi:10.1038/342929a0 · Cited by 1,081
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship
Strasser, A., Harris, A. W., & Cory, S. (1991) · Cell · doi:10.1016/0092-8674(91)90362-3 · Cited by 1,054
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2
Strasser, A., Harris, A. W., Bath, M. L., & Cory, S. (1990) · Nature · doi:10.1038/348331a0 · Cited by 905
Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation.
Pezzella, F., Tse, A. G. D., Cordell, J. L., Pulford, K. A. F., Gatter, K. C., & Mason, D. Y. (1990) · Europe PMC (PubMed Central) · Cited by 595
Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis
Gregory, C. D., Dive, C., Henderson, S., Smith, C. A., Williams, G. T., Gordon, J., & Rickinson, A. B. (1991) · Nature · doi:10.1038/349612a0 · Cited by 506
Martin, S. J., Lennon, S. V., Bonham, A. M., & Cotter, T. G. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.6.1859 · Cited by 483
Liu, Y., Mason, D. Y., Johnson, G. D., Abbot, S., Gregory, C. D., Hardie, D. L., Gordon, J., & MacLennan, I. C. M. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210819 · Cited by 435
Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex.
McConkey, D. J., Hartzell, P., Amador-Pérez, J. F., Orrenius, S., & Jondal, M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.6.1801 · Cited by 303
Liu, Y., Cairns, J. A., Holder, M. J., Abbot, S. D., Jansen, K. U., Bonnefoy, J., Gordon, J., & Maclennan, I. C. M. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210504 · Cited by 256
Collins, R. J., Verschuer, L. A., Harmon, B. V., Prentice, R. L., Pope, J. H., & Kerr, J. F. R. (1989) · British Journal of Haematology · doi:10.1111/j.1365-2141.1989.tb04290.x · Cited by 253
Anti‐immunoglobulins induce death by apoptosis in WEHI‐231 B lymphoma cells
Benhamou, L. E., Cazenave, P., & Sarthou, P. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200630 · Cited by 228
B cell growth-promoting activity of recombinant human interleukin 4.
Defrance, T., Vanbervliet, B., Aubry, J. P., Takebe, Y., Arai, N., Miyajima, A., Yokota, T., Lee, F., Arai, K. I., & de Vries, J. E. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.4.1135 · Cited by 205
Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells
McConkey, D. J., Aguilar-Santelises, M., Hartzell, P., Eriksson, I., Mellstedt, H., Orrenius, S., & Jondal, M. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.3.1072 · Cited by 172
Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms
Zutter, M., Hockenbery, D., Silverman, G., & Korsmeyer, S. (1991) · Blood · doi:10.1182/blood.v78.4.1062.1062 · Cited by 166
Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia.
Adachi, M., Tefferi, A., Greipp, P. R., Kipps, T. J., & Tsujimoto, Y. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.2.559 · Cited by 164
IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis
Zubiaga, A. M., Munoz, E., & Huber, B. T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.1.107 · Cited by 163
Reed, J. C., Cuddy, M., Haldar, S., Croce, C. M., Nowell̀, P. C., Makover, D., & Bradley, K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3660 · Cited by 154
Glucocorticoids suppress the production of interleukin 4 by human lymphocytes
Wu, C. Y., Fargeas, C. A., Nakajima, T., & Delespesse, G. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211053 · Cited by 140
Self-citationCD23 antigen regulation and signaling in chronic lymphocytic leukemia.
Fournier, S., Delespesse, G., Rubio, M., Biron, G., & Sarfati, M. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115717 · Cited by 69
Self-citationIgE synthesis by chronic lymphocytic leukemia cells.
Sarfati, M., Luo, H., & Delespesse, G. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.5.1775 · Cited by 47
Self-citationAntiproliferative Effect of Interleukin-4 in B Chronic Lymphocytic Leukemia
Luo, H., Rubio, M., Biron, G., Delespesse, G., & Sarfati, M. (1991) · Journal of Immunotherapy · doi:10.1097/00002371-199112000-00005 · Cited by 34
Self-citation
Cited by
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524
Tumor microenvironment and therapeutic response
Wu, T., & Dai, Y. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.01.043 · Cited by 1,802
The IL-4 receptor: signaling mechanisms and biologic functions
Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J., & Paul, W. E. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.701 · Cited by 1,545
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4
Todaro, M., Alea, M. P., Di Stefano, A. B., Cammareri, P., Vermeulen, L., Iovino, F., Tripodo, C., Russo, A., Gulotta, G., Medema, J. P., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.001 · Cited by 1,039
A rapid and simple method for the isolation of apoptotic DNA fragments
Herrmann, M., Lorenz, H.-M., Voll, R., Griinke, M., Woith, W., & Kalden, J. R. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.24.5506 · Cited by 653
Metadata
- Authors
- Dancescu, M., Rubio-Trujillo, M., Biron, G., Bron, D., Delespesse, G., & Sarfati, M.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1992-11-01
- Volume
- 176
- Issue
- 5
- Pages
- 1319-1326
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2023400811
- Cited by
- 344
- References
- 28
- FWCI
- 14.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.